Related Experiment Video
Updated: Jul 5, 2026

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies
Published on: August 8, 2019
Targeting a tumor-specific laminin domain critical for human carcinogenesis
Mark Tran1, Patricia Rousselle, Pasi Nokelainen
1Program in Epithelial Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Abstract:
Laminin-332 is critical for squamous cell carcinoma (SCC) tumorigenesis, but targeting it for cancer therapy has been unachievable due to key role of laminin-332 in promoting tissue integrity. Here, we show that a portion of laminin-332, termed G45, which is proteolytically removed and absent in normal tissues, is prominently expressed in most human SCC tumors and plays an important role in human SCC tumorigenesis. Primary human keratinocytes lacking G45 (DeltaG45) showed alterations of basal receptor organization, impaired matrix deposition, and increased migration. After SCC transformation, the absence of G45 domain in DeltaG45 cells was associated with deficient extracellular signal-regulated kinase and phosphotidylinositol 3-kinase (PI3K) pathway activation, impaired invasion, deficient metalloproteinase activity, and absent tumorgenicity in vivo. Expression of G45 or activated PI3K subunit in DeltaG45 cells reversed these abnormalities. G45 antibody treatment induced SCC tumor apoptosis, decreased SCC tumor proliferation, and markedly impaired human SCC tumorigenesis in vivo without affecting normal tissue adhesion. These results show a remarkable selectivity of expression and function for laminin-332 G45 in human SCC tumorigenesis and implicate it as a specific target for anticancer therapy.
Insights
The G45 fragment of laminin-332, absent in normal tissues but present in squamous cell carcinoma (SCC) tumors, drives SCC tumorigenesis. Targeting G45 selectively inhibits SCC growth without harming healthy tissues, offering a novel cancer therapy approach.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Laminin-332 is crucial for squamous cell carcinoma (SCC) development.
- Targeting laminin-332 for cancer therapy is challenging due to its role in tissue integrity.
Purpose of the Study:
- To investigate the specific role of the G45 fragment of laminin-332 in human SCC tumorigenesis.
- To evaluate G45 as a potential therapeutic target for SCC.
Main Methods:
- Generated human keratinocytes lacking the G45 domain (DeltaG45).
- Analyzed cellular behavior, signaling pathways (ERK, PI3K), and matrix metalloproteinase activity in DeltaG45 cells.
- Assessed the in vivo tumorigenicity of DeltaG45 cells and the effects of G45 antibody treatment on SCC tumors.
Main Results:
- The G45 fragment is prominently expressed in human SCC tumors but absent in normal tissues.
- DeltaG45 keratinocytes exhibited altered receptor organization, impaired matrix deposition, and increased migration.
- Absence of G45 in SCC cells led to deficient PI3K/ERK pathway activation, impaired invasion, reduced metalloproteinase activity, and loss of tumorigenicity.
- G45 expression or PI3K activation restored normal cellular functions in DeltaG45 cells.
- G45 antibody treatment induced SCC apoptosis, reduced proliferation, and inhibited tumor growth in vivo without affecting normal tissue adhesion.
Conclusions:
- The laminin-332 G45 fragment displays selective expression and function in human SCC tumorigenesis.
- G45 is a specific and promising therapeutic target for squamous cell carcinoma treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
lncRNA - Long Non-coding RNAs
Laminins are the Adhesive Proteins of Basal Lamina
In humans, the five forms of alpha chains are LAMA 1, LAMA 2, LAMA 3, LAMA 4, and LAMA 5. The four forms of beta chains are LAMB 1, LAMB 2, LAMB 3, and LAMB 4. The three forms of gamma...
